Encompass Health Corporation EHC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.50% | 8.30% | 28.38% | 20.84% | 16.91% |
| Total Depreciation and Amortization | 12.62% | 13.14% | 10.23% | 10.77% | 5.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -1.03% | -- |
| Total Other Non-Cash Items | 18.47% | 25.53% | -0.46% | 33.53% | 23.41% |
| Change in Net Operating Assets | 2,572.22% | -594.87% | -350.67% | 396.43% | -94.46% |
| Cash from Operations | 33.68% | 4.59% | 8.49% | 24.10% | 1.12% |
| Capital Expenditure | -25.33% | -40.41% | 0.43% | -15.40% | -26.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.00% | -80.00% | 167.39% | -102.00% | -1.43% |
| Cash from Investing | -20.02% | -42.44% | 5.30% | -17.53% | -24.64% |
| Total Debt Issued | 117.25% | -- | 600.00% | 133.33% | 433.33% |
| Total Debt Repaid | -92.91% | -3,015.25% | -312.50% | 76.06% | 30.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -132.53% | -199.19% | -97.50% | -918.67% | -266.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.00% | -10.53% | -12.78% | -11.76% | -13.33% |
| Other Financing Activities | 3.04% | -50.38% | -72.10% | -12.56% | -157.86% |
| Cash from Financing | -35.78% | 14.75% | 21.40% | 35.45% | -26.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.80% | -304.79% | 20,266.67% | 112.14% | -360.12% |